An unknown buyer agreed to acquire Hung Chun Bio-S Tech Co., Ltd. from Coland Holdings Limited (TSEC:4144) for TWD 82.9 million on March 24, 2017. Under the terms of agreement, 4.8 million shares have been acquired for TWD 17.27 per share. In a related transaction, Coland Holdings Limited sold Revlis Biotech Co., Ltd., and CDIB Healthcare Fund Ltd. Central Chief Limited sold Joinsmart Biomedical Co., Ltd. The transaction is subject to approval by the relevant organization in charge in Taiwan. An unknown buyer cancelled the acquisition of Hung Chun Bio-S Tech Co., Ltd. from Coland Holdings Limited (TSEC:4144) on March 24, 2018.